UBS Group’s AllianzIM U.S. Equity Buffer10 Dec ETF DECT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-28
Closed -$995 10547
2026
Q1
$995 Buy
+28
New +$1.02K ﹤0.01% 9660
2025
Q4
Sell
-7
Closed -$248 10617
2025
Q3
$248 Sell
7
-993
-99% -$34.1K ﹤0.01% 9784
2025
Q2
$33.4K Sell
1,000
-1,260
-56% -$39.7K ﹤0.01% 8088
2025
Q1
$70.1K Buy
+2,260
New +$72.3K ﹤0.01% 7327
2024
Q4
Sell
-168
Closed -$5.35K 10007
2024
Q3
$5.35K Buy
+168
New +$5.26K ﹤0.01% 8063
2024
Q2
Sell
-108
Closed -$3.25K 9616
2024
Q1
$3.25K Buy
+108
New +$3.17K ﹤0.01% 7755
2023
Q4
Sell
-23
Closed -$603 9397
2023
Q3
$603 Buy
+23
New +$625 ﹤0.01% 8383
2023
Q2
Sell
-3,464
Closed -$88K 9028
2023
Q1
$88K Buy
+3,464
New +$86.1K ﹤0.01% 6006

Other funds holding DECT

UBS Group's DECT Position: Q2 2026 in Review

UBS Group sold out of AllianzIM U.S. Equity Buffer10 Dec ETF (DECT) in Q2 2026, closing a stake of 28 shares — an estimated $995 sold.

UBS Group first reported a position in DECT in Q1 2023 and held it in 8 quarters. The position peaked at $88K in Q1 2023. 48 funds tracked by Wall St. Rank hold DECT as of Q2 2026.

  • UBS Group reported no remaining AllianzIM U.S. Equity Buffer10 Dec ETF position as of Q2 2026 after selling out during the quarter.
  • UBS Group sold 28 AllianzIM U.S. Equity Buffer10 Dec ETF shares in Q2 2026, an estimated $995.
  • UBS Group first reported a position in AllianzIM U.S. Equity Buffer10 Dec ETF in Q1 2023 and held it in 8 quarters.
  • UBS Group's AllianzIM U.S. Equity Buffer10 Dec ETF position peaked at $88K in Q1 2023.
  • 48 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Dec ETF as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.